This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Knowing what to avoid when budgeting helps you stay on course. This piece highlights common missteps and practical countermeasures.
11,930 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Is a stock market crash 2026? on the horizon. This guide translates fear into a concrete action plan—emergency funds,...
Seoul lawmakers push to scrap the 22% crypto gains tax slated for 2025, arguing the policy is unfair to everyday inve...
A new AI image generator from Microsoft, MAI-Image-2, promises sharper visuals and reliable text rendering. This arti...
A leading home improvement stock fell 40% last quarter as growth cooled, triggering a $14 million trimming of a major...
A major institutional move has trimmed a niche ETF position. Perritt Capital Management exited its Vanguard Internati...
As March closes, a simple, disciplined core holding stands out for many investors: the Vanguard S&P 500 ETF (VOO). Th...
As the Fed's path becomes less predictable, investors weigh how many rate cuts to expect in 2026. This guide breaks d...
Palantir is venturing into a new market via Polymarket, sparking questions about its AI growth path. This guide lays ...
A big investor recently unloaded $7.8 million worth of Harrow stock. This article breaks down whether that move signa...
SoFi faced a high-profile attack from a famed short-seller, sending shares lower. This deep dive explains what the re...
JetBlue Airways sparked a rally as reports surfaced about a strategic review, including a possible sale. Here’s what ...